Horse News and Research

RSS

Scientist finds man-made chemical enzyme to neutralize toxin

For the first time ever, a completely man-made chemical enzyme has been successfully used to neutralise a toxin found naturally in fruits and vegetables. While studying for her PhD in chemistry at the University of Copenhagen Dr. Jeannette Bjerre showed how a novel so called chemzyme was able to decompose glycoside esculin, a toxin found in horse-chestnuts.

27 Aug 2010

Tobacco companies use web 2.0 media to get around marketing restrictions

Tobacco companies may be using web 2.0 media, such as YouTube, to market their products to young people, so getting round marketing restrictions for tobacco content in place elsewhere, suggests research published online in Tobacco Control.

26 Aug 2010

Brain trauma in sports associated with motor neuron disease, researchers find

The Center for the Study of Traumatic Encephalopathy at Boston University School of Medicine and Department of Veterans Affairs announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is associated with motor neuron disease, a neurological condition that affects voluntary muscle movements.

18 Aug 2010

New implantable device to prevent sudden cardiac arrest

Northwestern Memorial Hospital heart rhythm specialists recently gave a 34-year-old man a makeshift paramedic—who's always on duty—inside of his chest by implanting a device that did not require X-ray assistance and the usual snaking of wires leading to the heart. In fact, the innovative device rests just beneath the surface of the skin and its components are positioned using the patient's own anatomical landmarks.

13 Aug 2010

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

Underscoring that a sudden cardiac arrest emergency requires quick response and that automated external defibrillators are easy to use, the Eastern Pennsylvania Chapter of the Sudden Cardiac Arrest Association has launched a unique community response team with the Amish community of Lancaster County, Pennsylvania, at the center of a broad program that will deploy AEDs in public locations, schools and even on horse and buggies and Amish farms to protect the community's residents and visitors from the nation's leading cause of death.

12 Aug 2010

Researchers identify perforant path brain passage associated with Alzheimer's disease

With the help of volunteers aged 18 to 89, UC Irvine researchers have identified for the first time in humans a long-hidden part of the brain called the perforant path. Scientists have struggled for decades to locate the tiny passage, which is believed to deteriorate gradually as part of normal aging and far more quickly due to Alzheimer's disease.

11 Aug 2010

Genetic factors lead to meningitis development: Study

Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people, published today in Nature Genetics.The research, led by Imperial College London and the Genome Institute of Singapore, is the largest ever genetic study of meningitis and septicaemia caused by meningococcal bacteria. It suggests that people who develop these diseases have innate differences in their natural defences that leave them unable to attack meningococcal bacteria successfully.

9 Aug 2010

Scientists develop novel chemotherapeutic method for anticancer drug delivery

Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.

28 Jul 2010

Campaign for safe horse riding

A recent UK HealthCare survey found that 60 percent of Kentucky horseback riding respondents did not wear any safety apparel the last time they went riding.

26 Jul 2010

SWHR hosts briefing on urinary incontinence, overactive bladder

The Society for Women's Health Research (SWHR) hosted the Capitol Hill briefing, The Bladder Matters: What Women Need to Know on Thursday, July 15, which highlighted startling statistics and an insightful patient perspective. Featuring noted researchers, physicians, Hill staff, and a UI-afflicted patient, the aim of this widely attended briefing was to detail current research on urinary incontinence (UI) and present future outlooks.

22 Jul 2010

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport.

17 Jul 2010

Study shows high rate of return to pre-injury level of function with arthroscopic treatment

Athletes who undergo arthroscopic surgery for a mechanical disorder of the hip have a good chance of being able to return to their sport at a high level of competition, according to a study that will be presented at the annual meeting of the American Orthopaedic Society for Sports Medicine, held July 15-18 in Providence, R.I. Almost 80 percent of patients were able to return to play after hip arthroscopy at an average of 9.4 months after surgery, and roughly 90 percent were able to return to the same level of competition.

16 Jul 2010

Spanish scientists develop new parasite detection method to prevent Anisakidosis

A new method enables anisakids to be detected in any fish product, from a whole fish, fresh or frozen, to tinned fish and surimi. Developed by Spanish scientists, the system is based on molecular techniques and overcomes the limitations of traditional procedures.

16 Jul 2010

Access announces agreement to develop oral formulation of proprietary injectable drugs

Access Pharmaceuticals, Inc., announced today that it has entered into a pre-licensing feasibility agreement with a leading biotechnology company to develop an oral formulation of its currently-marketed, proprietary injectable drugs. Access will utilize its proprietary Cobalamin Oral Drug Delivery Technology to develop oral formulations of the drug for pre-clinical testing.

15 Jul 2010

Hendra virus treatment to be ready in a few months

Of the dozen people who were exposed to a horse infected with the Hendra virus, 11 have been cleared of the infection by repeated tests on Queensland's Sunshine Coast. These 12 people had first come into contact with the infected horse at Tewantin in May and have since then been subjected to testing to rule out infection with the deadly virus. It is expected that the 12th person will also be cleared soon. Quarantine restrictions were also lifted last month.

14 Jul 2010

Lawmakers, pundits offer mixed reaction to Berwick appointment

Politicians and pundits are reacting to President Barack Obama's recess appointment of Dr. Donald Berwick to run Medicare and Medicaid, with some saying such an appointment bypasses an important process while others praise the move.

9 Jul 2010

Elements Behavioral Health acquires The Ranch in Tennessee

Elements Behavioral Health, provider of residential treatment services for addiction and co-occurring disorders, announced this week the acquisition of The Ranch in Nunnelly, Tennessee. Elements is best known to the public as the owner of the internationally famous Promises Treatment Centers in Malibu and Los Angeles, where many Hollywood celebrities have been treated successfully for substance abuse.

2 Jul 2010

Horse News and Research

Scientist finds man-made chemical enzyme to neutralize toxin

Tobacco companies use web 2.0 media to get around marketing restrictions

Brain trauma in sports associated with motor neuron disease, researchers find

New implantable device to prevent sudden cardiac arrest

Eastern Pennsylvania Sudden Cardiac Arrest Association launches response team with Amish community

Researchers identify perforant path brain passage associated with Alzheimer's disease

Genetic factors lead to meningitis development: Study

Scientists develop novel chemotherapeutic method for anticancer drug delivery

Campaign for safe horse riding

SWHR hosts briefing on urinary incontinence, overactive bladder

ArmaGen uses BBB molecular Trojan horse platform technology to create brain penetrating form of human EPO

Study shows high rate of return to pre-injury level of function with arthroscopic treatment

Spanish scientists develop new parasite detection method to prevent Anisakidosis

Access announces agreement to develop oral formulation of proprietary injectable drugs

Hendra virus treatment to be ready in a few months

Lawmakers, pundits offer mixed reaction to Berwick appointment

Elements Behavioral Health acquires The Ranch in Tennessee

Sleep enhances ability to remember to do something in future

Research findings open door to development of new therapies for lymphomas, leukemias

Light therapy may be alternative treatment for prostate cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News